title: Elevated soluble CD 27 levels (TNF-receptor) may predict survival in diffuse large B-cell lymphoma--revisiting "the super- family " saga.
authors.affiliation: Hematology Unit, Bnai-Zion Medical Center, Haifa, Israel. Tamar.tadmor@b-zion.org.il
authors.forename: Tamar
authors.initials: T
authors.lastname: Tadmor
authors.forename: Aaron
authors.initials: A
authors.lastname: Polliack
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000097:blood* / Q000188:drug therapy*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7 / Q000097:blood*; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone